UNSPSC 51461520: Arnica

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MUE8Y11327, which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 36554 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Asterales, Family Asteraceae, Genus Arnica L., more commonly known as ARNICA or the SUNFLOWER genus.

UNSPSC 51461520 Arnica (Commodity) encompasses pharmaceutical and over-the-counter products that state and local governments procure through cooperative purchasing vehicles and direct supply agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body reflected in recent activity under this code. The scope of work includes supply of generic multi-source pharmaceuticals and OTC products to state and local government facilities across participating jurisdictions, with vendors required to maintain relationships with authorized wholesalers, comply with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), and provide detailed product information including National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage form, and trade names. Evaluation criteria emphasize price competitiveness at 75 percent weight, with secondary consideration of fixed pricing, administrative fee compliance, EDI capability, and pricing flexibility through flat price, net price formats (NF30, NF60, NF90), or WAC-minus structures. Vendors must carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence and network security and privacy liability of $2,000,000, and products must possess expiration dates of at least one year from manufacture with a minimum six-month shelf life.

MMCAP's RFP for Generic Multi-Source Pharmaceuticals and Over the Counter Products (Solicitation Number S1070000015802) represents the recent activity under this code, with a proposal due date of March 26, 2026. The solicitation covers participating state and local government facilities in Minnesota, Oregon, and other MMCAP member jurisdictions. The contract term is two years for new responders with optional extensions at MMCAP's sole discretion, while incumbent responders' amendments align with existing agreement expiration dates through June 30, 2028. All products must be available in the marketplace by May 15, 2026, with the resulting agreements effective July 1, 2026. Vendors should anticipate a 3 percent administrative fee on all contract purchases and compliance with performance penalties ranging from $200 to $1,500 per violation. No specific award values or budget ranges are disclosed in available documentation.